BG
NHC icon

Bahl & Gaynor’s National Healthcare NHC Stock Holding History

Bahl & Gaynor’s Portfolio NHC Stock Details NHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35,023
Closed -$2.73M – 348
2021
Q1 		$2.73M Buy
35,023
+644
+2% +$45.6K 0.02% 213
2020
Q4 		$2.28M Sell
34,379
-73
-0.2% -$4.81K 0.01% 226
2020
Q3 		$2.15M Sell
34,452
-21,750
-39% -$1.36M 0.02% 218
2020
Q2 		$3.57M Buy
56,202
+223
+0.4% +$14.9K 0.03% 165
2020
Q1 		$4.02M Sell
55,979
-148
-0.3% -$11.7K 0.04% 143
2019
Q4 		$4.85M Buy
56,127
+2,022
+4% +$169K 0.03% 148
2019
Q3 		$4.43M Buy
54,105
+4,229
+8% +$350K 0.03% 155
2019
Q2 		$4.05M Buy
49,876
+4,565
+10% +$352K 0.03% 160
2019
Q1 		$3.44M Buy
45,311
+12,760
+39% +$1.01M 0.03% 159
2018
Q4 		$2.55M Buy
32,551
+12,875
+65% +$1.01M 0.03% 177
2018
Q3 		$1.48M Sell
19,676
-3,071
-14% -$226K 0.02% 240
2018
Q2 		$1.6M Buy
22,747
+4,556
+25% +$298K 0.02% 231
2018
Q1 		$1.08M Sell
18,191
-455
-2% -$27.9K 0.01% 272
2017
Q4 		$1.14M Buy
18,646
+4,265
+30% +$272K 0.01% 269
2017
Q3 		$899K Buy
14,381
+2,441
+20% +$157K 0.01% 272
2017
Q2 		$837K Buy
11,940
+610
+5% +$43.6K 0.01% 285
2017
Q1 		$808K Buy
11,330
+250
+2% +$18.5K 0.01% 274
2016
Q4 		$840K Buy
11,080
+770
+7% +$53.4K 0.01% 260
2016
Q3 		$680K Buy
10,310
+505
+5% +$32.8K 0.01% 285
2016
Q2 		$635K Buy
9,805
+715
+8% +$45.4K 0.01% 286
2016
Q1 		$566K Buy
9,090
+10
+0.1% +$623 0.01% 297
2015
Q4 		$560K Buy
9,080
+220
+2% +$14.3K 0.01% 299
2015
Q3 		$539K Buy
8,860
+205
+2% +$12.8K 0.01% 305
2015
Q2 		$562K Buy
8,655
+2,935
+51% +$186K 0.01% 314
2015
Q1 		$364K Buy
+5,720
New +$363K ﹤0.01% 348

Other funds holding NHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bahl & Gaynor's NHC Position: Q2 2021 in Review

Bahl & Gaynor sold out of National Healthcare (NHC) in Q2 2021, closing a stake of 35,023 shares — an estimated $2.73M sold.

Bahl & Gaynor first reported a position in NHC in Q1 2015 and held it in 25 quarters. The position peaked at $4.85M in Q4 2019. 139 funds tracked by Wall St. Rank hold NHC as of Q2 2021.

  • Bahl & Gaynor reported no remaining National Healthcare position as of Q2 2021 after selling out during the quarter.
  • Bahl & Gaynor sold 35,023 National Healthcare shares in Q2 2021, an estimated $2.73M.
  • Bahl & Gaynor first reported a position in National Healthcare in Q1 2015 and held it in 25 quarters.
  • Bahl & Gaynor's National Healthcare position peaked at $4.85M in Q4 2019.
  • 139 funds tracked by Wall St. Rank held National Healthcare as of Q2 2021.

Based on Bahl & Gaynor's 13F filing for Q2 2021, filed 6 Aug 2021.